MedPath

A prospective Multicenter Randomized Study Comparing Photoselective Vaporization of the Prostate with the GreenLight XPS Laser System and Transurethral resection of the Prostate for Treatment of benign Prostatis Hyperplasia

Phase 3
Completed
Conditions
10036958
Benign Prostate Hyperplasia
Registration Number
NL-OMON36344
Lead Sponsor
American Medical Systems
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
45
Inclusion Criteria

The patient is candidate for desobstructive surgery of the prostate due to symptomatic BPH by TURP or PVP
The IPSS score is > 12
Qmax < 15 ml/sec
Prostate Volume < 100 cc

Exclusion Criteria

Life expectancy < 2 years
Active Urinary Tract Infection
Prostatitis
Neurogenic bladder
Diagnosis prostate carcinoma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>To demonstrate that BPH symptoms after PVP are not worse when compared to TURP<br /><br>at 6 months post procedure measured via international prostate symptom score<br /><br>(IPSS) for the treatment of BPH. </p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath